A Philadelphia-area company got marketing approval Thursday for a blood test for mesothelioma, a form of cancer liked to asbestos exposure.
Fujirebio Diagnostics Receives FDA Approval for the MESOMARK(R) Assay for the Management of Mesothelioma Patients
MALVERN, Penn.—-Fujirebio Diagnostics, Inc. received approval from the Food & Drug Administration under the Humanitarian Device Exemption program for the MESOMARK Assay, the world’s first in-vitro test for mesothelioma, a form of cancer linked to asbestos exposure.
Primary Peritoneal Serous Borderline Tumors
By Hutton, Robert L; Dalton, Scott R * Context.-Primary peritoneal serous borderline tumor is a rare epithelial proliferation that can present as an incidental finding at laparotomy and raises concern for a primary ovarian tumor with peritoneal implants.